Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastomaLaurèl Rauschenbach, Björn Scheffler, Anja Wieland et al.|European Journal of Cancer|2020Cited by 22
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Johann Matschke et al.|Clinical Cancer Research|2022Cited by 4
Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0
Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Björn Scheffler, Vivien Ullrich et al.|Unknown|2023Cited by 0